Patent US4054488A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4054488A Expired / Lapsed US ⏱️ 0.0 years remaining

Preservation of glucose in blood samples

Assignee: Individual
•
Filing: 1976-02-26
•
Granted: 1977-10-18
•
Expires: 1996-02-26
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A process and preservatives for preventing glycolysis in blood samples so as to preserve the glucose content and lactic acid content thereof. The preservatives do not produce any significant hemolysis in the blood sample, and they do not interfere with any of the known blood constituents. The preservatives comprise salts of Iodoacetic acid, such as Tris-Iodoacetate [(CH 2 OH) 3 NH 3 CO 2 -- CH 2 I]; salts of Bromoacetic acid, such as Tris-Bromoacetate [(CH 2 OH) 3 NH 3 CO 2 -- CH 2 Br], or Sodium Bromoacetate [NaO 2 CCH 2 Br]; and salts of mono Chloroacetic acid (ClCH 2 COOH), such as Sodium Chloroacetate (NaO 2 CCH 2 Cl).

Inventors

  • 👤 Edward P. Marbach

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 11:40
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/66; Y; Y10; Y10T; Y10T436/00; Y10T436/10; Y10T436/104998; Y10T436/105831; Y10T436/106664; Y10T436/108331

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 39 words
A preserved sample including whole blood and a preservative to preserve the glucose content of said whole blood, said preservative being selected from a group consisting of Tris-Iodoacetate, a salt of Bromoacetic acid or a salt of Chloroacetic acid.
Claim 2
Dependent Claim 39 words
A preserved sample including whole blood and a preservative to preserve the glucose content of said whole blood, said preservative being selected from a group consisting of Tris-Iodoacetate, a salt of Bromoacetic acid or a salt of Chloroacetic acid.
Claim 3
Dependent Claim 25 words
The preserved sample defined in claim 1, in which the preservative is Tris-Iodoacetate in a concentration of substantially 3 milligrams per milliliter of whole blood.
Claim 4
Dependent Claim 24 words
The preserved sample defined in claim 1, in which said preservative is selected from a group consisting of Tris-Bromoacetate Sodium Bromoacetate or Sodium Chloroacetate.
Claim 5
Dependent Claim 32 words
The preserved sample defined in claim 3, in which the concentration of the preservative in the whole blood is substantially a range of 0.1-3 milligrams of preservative per milliliter of whole blood.
Claim 6
Dependent Claim 35 words
The preserved sample defined in claim 3, in which the preservative is selected from a group consisting of Sodium Bromoacetate or Sodium Chloroacetate in a concentration of substantially 1.5 milligrams per milliliter of whole blood.
Claim 7
Dependent Claim 38 words
A process for preventing glycolysis in a whole blood sample which comprises adding a preservative selected from a group consisting of Tris-Iodoacetate, a salt of Bromoacetic acid or a salt of Chloroacetic acid to the whole blood sample.
Claim 8
Dependent Claim 38 words
A process for preventing glycolysis in a whole blood sample which comprises adding a preservative selected from a group consisting of Tris-Iodoacetate, a salt of Bromoacetic acid or a salt of Chloroacetic acid to the whole blood sample.
Claim 9
Dependent Claim 24 words
The process defined in claim 6, in which the preservative is Tris-Iodoacetate in a concentration of substantially 3 milligrams per milliliter of whole blood.
Claim 10
Dependent Claim 32 words
A process for preventing glycolysis in a whole blood sample which comprises adding a preservative selected from a group consisting of Tris-Bromoacetate Sodium Chloroacetate or Sodium Bromoacetate to the whole blood sample.
Claim 11
Dependent Claim 32 words
A process for preventing glycolysis in a whole blood sample which comprises adding a preservative selected from a group consisting of Tris-Bromoacetate Sodium Chloroacetate or Sodium Bromoacetate to the whole blood sample.
Claim 12
Dependent Claim 33 words
The process defined in claim 8, in which the concentration of the preservative in the whole blood sample is substantially in the range of 0.1-3 milligrams of preservative per milliliter of whole blood.
Claim 13
Dependent Claim 25 words
The process defined in claim 8, in which the preservative is Sodium Chloroacetate in a concentration of substantially 1.5 milligrams per milliliter of whole blood.

References Cited (Backward Citations)

US3629142A Cited
US3682835A Cited
US3847738A Cited
US3874384A Cited
US3859049A Cited
US3873467A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-10-17 1981-04-18 1981-10-18 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-10-17 1985-04-18 1985-10-18 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-10-17 1989-04-18 1989-10-18 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag